Assessment of the implementation of the EU Drugs Strategy 2005—2012 and its Action Plans
Illicit drug use continues to be an important public health and safety concern in Europe. Production, trafficking and dealing in illicit drugs constitute important criminal justice challenges in themselves, and are associated with other criminal activities. The 2005-2012 EU Drugs Strategy (as with previous strategies) was developed to complement and add value to national strategies and approaches while respecting the principles of subsidiarity and proportionality set out in the EU Treaties. The main rationale for its development was that while drugs problems vary across Member States, and are experienced at the local and national level, they are "a global issue that needs to be addressed in a transnational context". RAND Europe undertook an independent evaluation of the current Strategy and its Action Plans, addressing four research objectives:
- To assess barriers and facilitators to the implementation of objectives and priorities at EU and Member State level
- To assess the relevance and influence of the Strategy with respect to national drugs policy and legislation
- To assess possible impact on the drugs situation in the EU
- To identify key aspects and recommendations for future EU Drugs Strategies
- Copyright: European Communities
- Publisher: RAND Corporation
- Availability: Web-Only
- Pages: 233
- Document Number: TR-1228-EC
- Year: 2012
- Series: Technical Reports
The EU Drugs Strategy and its context
Background to drugs policy in the EU
The EU Drugs Strategy 2005-2012
Assessment of the EU Drugs Strategy
Information, research and evaluation
Interview protocol – key informant interviews
Interview protocol – EU level in-depth interviews
Interview protocol – Member State level in-depth interviews
Questions in the EEAS survey
Findings from the EEAS survey
Case study objectives for implementation: data summary tables
List of documents consulted
The research described in this report was prepared for the European Commission Directorate General for Justice and conducted by RAND Europe.
This report is part of the RAND Corporation technical report series. RAND technical reports may include research findings on a specific topic that is limited in scope or intended for a narrow audience; present discussions of the methodology employed in research; provide literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; or deliver preliminary findings. All RAND reports undergo rigorous peer review to ensure that they meet high standards for research quality and objectivity.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.